Clinical Trial Update: Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluates the efficacy and safety of combining daclatasvir and asunaprevir for chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)
• Daklinza (Daclatasvir)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Hepatitis C, Chronic | Phase 4 | Status: UNKNOWN